Skip to content
healthcare.dev

Methotrexate

NDC 59651-182, Methotrexate, tablet, from Aurobindo Pharma Limited.

Product NDC
59651-182
Status
Listed
Labeler
Aurobindo Pharma Limited
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA210454
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/59651-182 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • METHOTREXATE SODIUM2.5 mg/1

Pharmacologic classes

Folate Analog Metabolic Inhibitor [EPC]; Folic Acid Metabolism Inhibitors [MoA]

Package NDCNDC-11Package
59651-182-0159651018201100 TABLET in 1 BOTTLE (59651-182-01)
59651-182-365965101823636 TABLET in 1 BOTTLE (59651-182-36)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/09931d44-a3f8-49dc-a3f2-b527ee4214bf
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=59651-182
  • NADAC price for package 59651018201

    GET /v1/drugs/nadac/59651018201

Use it

Look up 59651-182 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/59651-182 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 59651-182. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.